There has long been a wall separating adult rheumatologists from pediatric rheumatologists. A recent review article published in the January edition of Arthritis & Rheumatology (A&R) suggests that genetics, rather than age, may be a better way to categorize forms of primary inflammatory arthritis across the lifespan.1 “Pediatric and adult rheumatologists don’t generally interact that…
SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting Nov. 3–8, experts discussed improving bone health in the U.S., gave tips on bone health disorders in pediatrics and reviewed new translational science findings for joint conservation in early osteonecrosis. E. Michael Lewiecki, MD, director of the New Mexico Clinical Research & Osteoporosis Center in Albuquerque, N.M., called…
Two Phase 3 trials have shown that epratuzumab did not meet its primary endpoints for treating SLE. Meanwhile, a Phase 3 study has shown adalimumab is effective for treating enthesitis-related arthritis in juveniles…
How to recognize distinctions between pediatric and adult arthritis
A Foundation grant is helping investigators develop tools to measure and describe disease activity in juvenile arthritis patients
With teenaged juvenile arthritis patients, it’s important for rheumatologists to engage in conversations about how drugs, tobacco, alcohol, and sex will affect them
Information on New Approvals and Medication Safety
What is the pain puzzle? “It is a bio-psycho social model of pain that is accepted in the field of rheumatology,” according to Michael Rapoff, PhD, professor of pediatrics at the University of Kansas Medical Center in Kansas City and the highlighted speaker for the ARHP audioconference on April 17.
Hepatitis-C virus (HCV)-associated arthritis is highlighted this month in our ongoing series on patient education materials.
Handpicked Reviews of Contemporary Literature